Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation.

Raghavan K, Ikewaki N, Preethy S, Abraham SJK

Open source

DOI
10.3389/fgene.2025.1569289
Published
2025
Container
Frontiers in genetics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fgene.2025.1569289,
  title = {Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation.},
  author = {Raghavan K and Ikewaki N and Preethy S and Abraham SJK},
  year = {2025},
  journal = {Frontiers in genetics},
  doi = {10.3389/fgene.2025.1569289},
  url = {https://doi.org/10.3389/fgene.2025.1569289}
}

RIS

TY  - JOUR
TI  - Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation.
AU  - Raghavan K
AU  - Ikewaki N
AU  - Preethy S
AU  - Abraham SJK
PY  - 2025
JO  - Frontiers in genetics
DO  - 10.3389/fgene.2025.1569289
UR  - https://doi.org/10.3389/fgene.2025.1569289
ER  - 

APA

K, R., N, I., S, P., & SJK, A. (2025). Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation.. Frontiers in genetics. https://doi.org/10.3389/fgene.2025.1569289

Source records